GGrantIndex
Sort

15,842 grants matching pancreatic cancer

Exploring Glycobiology and Discovering Biomarkers for Pancreatic Cancer

$249,000
Dannielle Engle · Salk Institute For Biological Studies · R00 · FY2021 · CA

Integrating epidemiologic, clinical, genomic and metabolomic profiles to predict pancreatic cancer risk in a multiethnic population

$249,000
Brian Huang · University Of Southern California · R00 · FY2025 · CA

Cellular mechanisms and therapeutic possibilities of inhibiting oncogenic KRAS

$249,000
Andrew L Wolfe · Hunter College · R00 · FY2022 · CA

Machine Perception Nanosensor Array Platform to Capture Whole Disease Fingerprints of Early Stage Pancreatic Cancer

$249,000
Mijin Kim · Georgia Institute Of Technology · R00 · FY2024 · EB

The effects of Ojeok-san on neuro-immune interactions in cancer-induced visceral pain

$249,000
Kandy T Velazquez · University Of South Carolina At Columbia · R00 · FY2021 · AT

Investigating the metabolic regulation of tumor desmoplasia

$249,000
Simon Schwã–rer · University Of Chicago · R00 · FY2023 · CA

Origin, diversification and function of pancreatic cancer associated fibroblasts

$248,999
Lu Han · Medical University Of South Carolina · R00 · FY2024 · CA

Dissecting the Role of Germline Genetics in RAS-Driven Cancers

$248,999
Ryan Lewis Collins · Dana-Farber Cancer Inst · R00 · FY2025 · CA

Targeting Pancreatic Cancer Senescence with ImmunoPET

$248,999
Edwin Charles Pratt · State University New York Stony Brook · R00 · FY2025 · CA

Disrupting macrophage metabolism to reduce immunosuppression and enhance therapy in pancreatic cancer

$248,999
Christopher J. Halbrook · University Of California-Irvine · R00 · FY2020 · CA

Measuring and manipulating metabolic fluxes in the tumor microenvironment

$248,999
Caroline Bartman · University Of Pennsylvania · R00 · FY2025 · CA

Origin, diversification and function of pancreatic cancer associated fibroblasts

$248,999
Lu Han · Medical University Of South Carolina · R00 · FY2025 · CA

Interrogating the RAS interactome for therapeutic vulnerabilities

$248,999
Hema Adhikari · Washington University · R00 · FY2025 · CA

Targeting Malic Enzyme 3 as a Synthetic Lethality Target in Pancreatic Cancer

$248,999
Prasenjit Dey · Roswell Park Cancer Institute Corp · R00 · FY2019 · CA

Regulation of Ribosome Biogenesis During Stress

$248,999
Shawn M Lyons · Boston University Medical Campus · R00 · FY2021 · GM

Cellular and molecular delineation of pathologic fibroblasts in pulmonary fibrosis

$248,999
Tatsuya Tsukui · University Of California, San Francisco · R00 · FY2023 · HL

Regulation of Ribosome Biogenesis During Stress

$248,999
Shawn M Lyons · Boston University Medical Campus · R00 · FY2022 · GM

Interrogating the RAS interactome for therapeutic vulnerabilities

$248,999
Hema Adhikari · Washington University · R00 · FY2024 · CA

Understanding the effects of dietary interventions on pancreatic ductal adenocarcinoma therapy cancer

$248,982
Evan Chen Lien · Van Andel Research Institute · R00 · FY2023 · CA

Understanding the effects of dietary interventions on pancreatic ductal adenocarcinoma therapy cancer

$248,982
Evan Chen Lien · Van Andel Research Institute · R00 · FY2022 · CA

Biostatistics Shared Resource

$248,958
Elizabeth G Hill · Medical University Of South Carolina · P30 · FY2024 · CA

Cellular and molecular delineation of pathologic fibroblasts in pulmonary fibrosis

$248,947
Tatsuya Tsukui · University Of California, San Francisco · R00 · FY2024 · HL

Cellular and molecular delineation of pathologic fibroblasts in pulmonary fibrosis

$248,902
Tatsuya Tsukui · University Of California, San Francisco · R00 · FY2025 · HL

Detection and Diagnosis of Pancreatic Cancer

$248,879
David V Gold · Ctr For Molecular Medicine/Immunology · R56 · FY2009 · CA

Using markers to improve pancreatic cancer screening and surveillance

$248,872
Michael G. Goggins · Johns Hopkins University · U01 · FY2016 · CA